Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000020

Chief Commercial Officer gave up 742 shares (to pay taxes)

  • Chief Commercial Officer acquired 2,542 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Poddar Richa · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-18 Exercise or conversion : show line 1 in the form +1,884 4,525 D
2022-02-22 Exercise or conversion : show line 2 in the form +658 5,183 D
2022-02-22 Shares withheld for taxes : show line 3 in the form −742 $29.08 $21,577 4,441 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-18 Exercise or conversion : show line 4 in the form Performance share units −1,884 1,883 D
2022-02-22 Exercise or conversion : show line 5 in the form Restricted stock units −658 0 D
Loading xslF345X03/wf-form4_164565067739124.xml…